Overview
Featured Articles
HotAug 25, 2026
Hot Why PD-1 Is Hard to Replicate: What a CAS Review Maps Out for the Next Era of IO
A team at CAS used a comprehensive approach, including natural language processing (NLP), to analyze more than 350,000 immuno-oncology documents in the CAS Content Collection. This article draws on their review to examine the IO target landscape, with a focus on approved and clinical-stage candidates.
Read more
HotAug 3, 2026
Hot Application-Oriented Functional Cell Lines | Case Study Series
During drug development, functional cell lines are critical tools connecting drug design, in vitro functional validation, and clinical translational prediction, forming an essential foundation for drug efficacy assessment.
Read more
HotJul 14, 2026
Hot What Determines FcγR-CR T Function Beyond the Therapeutic Antibody?
Fcγ receptor-driven chimeric receptor T (FcγR-CR T) cells have emerged as a promising strategy for antibody-guided cell therapy. Unlike conventional CAR-T cells, which directly recognize tumor-associated antigens, FcγR-CR T cells rely on therapeutic antibodies to bridge engineered T cells and tumor cells.
Read moreExplore by Subtopics
Get ACRO Insights in Your Inbox
Receive expert perspectives, research trends, and workflow guidance across emerging therapeutic fields.
Get ACRO Insights in Your Inbox
Explore More Topics
Cell and Gene Therapy
Antibody-Drug Conjugates
CMC Manufacturing & QC
Bispecific Antibodies
Disease Areas
Vaccines
